Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Rights to Clinical Stage Compound for Dry Eye (civamide)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Medicine for treatment of dry eye disease. The rights include the clinical stage compound used for the treatment of dry eye.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer

Rights to Clinical Stage Compound for Dry Eye (civamide) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Rights to Clinical Stage Compound for Dry Eye (civamide)‘s full profile, request access.

Request full access to PitchBook